Richard Pratley

246PUBLICATIONS
537CO-AUTHORS
Preventative health careSport and exercise nutritionPharmacogenomicsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (246)

|Aug 13, 2026
Leave no one behind: optimizing kidney protection in type 1 diabetes.

|Aug 04, 2026
Design and baseline characteristics of the ZENITH high proteinuria trial testing zibotentan/dapagliflozin efficacy in CKD.

|Jul 30, 2026
Feasibility of Decentralised Response-Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease.

|Jul 28, 2026
Impact of Albuminuria-Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE Trials.

|Jul 22, 2026
SGLT2 inhibition modulates metabolic, vascular, and inflammatory molecular markers in the kidney in youth with type 1 diabetes.

|Jul 08, 2026
More Evidence, More Options, More Questions.

Pageof 41

Frequent Collaborators

43 joint publications

Peter Rossing

32 joint publications

Brendon L Neuen

26 joint publications

Clare G Arnott

23 joint publications

David Z I Cherney